Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary
Pathobiology · 2023
DOI: 10.1159/000529276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, 2023. Verfasst von Dávid Semjén und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical School and Clinical Centre, University of Pécs, Pécs, Hungary. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Kidney Failure, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
End-stage renal disease (ESRD) and acquired cystic kidney disease (ACKD) are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological features of RCCs developed in ESRD were investigated.
Methods
A database consisting of 34 tumors from 31 patients with ESRD among 2,566 nephrectomy samples of RCC was built. The demographic, clinical, and follow-up data along with pathological parameters were analyzed. The RCCs were diagnosed according to the current WHO Classification of Urinary and Male Genital Tumors.
Results
Twenty-two tumors developed in men and 12 in women, with a median age of 56 years (range: 27–75 years). The causes of ESRD were glomerulonephritis (n = 7), hypertensive kidney disease (n = 6), autosomal dominant polycystic kidney disease (n = 6), chronic pyelonephritis (n = 4), diabetic nephropathy (n = 3), chemotherapy-induced nephropathy (n = 1), and undetermined (n = 4). ACKD complicated ESRD in 12 patients. The following histological subtypes were identified: clear cell RCC (n = 19), papillary RCC (n = 5), clear cell papillary tumor (n = 5), ACKD RCC (n = 3), and eosinophilic solid and cystic RCC (n = 2). The median tumor size was 31 mm (range: 10–80 mm), and 32 tumors were confined to the kidney (pT1-pT2). There was no tumor-specific death during the period of this study. Progression was registered in 1 patient.
Conclusion
In our cohort, the most common RCC subtype was clear cell RCC (55%), with a frequency that exceeded international data appreciably (14–25%). The incidence of clear cell papillary tumor and ACKD RCC (14.7% and 8.5%) was lower than data reported in the literature (30% and 40%). Our results indicate a favorable prognosis of RCC in ESRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Medical School and Clinical Centre, University of Pécs, Pécs, Hungary.
- MedServ Ltd., Budapest, Hungary.
- Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
- Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.
- Pathology Unit, Fejér County Szent György University Teaching Hospital, Székesfehérvár, Hungary.
- Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Zitieren
APA
Semjén, D., Dénes, B., Somorácz, Á., Fintha, A., Forika, G., Jenei, A., Dobi, D., Micsik, T., Eizler, K. V., Giba, N., Sánta, F., Sejben, A., Iványi, B., & Kuthi, L. (2023). Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary. Pathobiology. https://doi.org/10.1159/000529276
Vancouver
Semjén D, Dénes B, Somorácz Á, Fintha A, Forika G, Jenei A, et al. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary. Pathobiology. 2023. doi:10.1159/000529276
BibTeX
@article{Semjn2023,
author = {Semjén, Dávid and Dénes, Borbála and Somorácz, Áron and Fintha, Attila and Forika, Gertrúd and Jenei, Alex and Dobi, Deján and Micsik, Tamás and Eizler, Kornélia Veronika and Giba, Nándor and Sánta, Fanni and Sejben, Anita and Iványi, Béla and Kuthi, Levente},
title = {Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary},
journal = {Pathobiology},
year = {2023},
doi = {10.1159/000529276}
}
EUVIMED